Spironolactone Versus Prednisolone in DMD
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin Flanigan, MD
Nationwide Children's Hospital
Principal Investigator - Megan Waldrop, MD
Nationwide Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Iowa
Iowa City, Iowa, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Dec 2018
- Primary completion
- 27 Sept 2021
- Completion
- 30 Nov 2021
- Last update posted
- 23 Oct 2023
- Registered enrollment
- 2
- Registry id
- NCT03777319
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.